Killen Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q1 | $20.8M | Sell |
409,458
-45,021
| -10% | -$2.28M | 2.4% | 8 |
|
2015
Q4 | $22.9M | Sell |
454,479
-10,559
| -2% | -$533K | 2.37% | 6 |
|
2015
Q3 | $22.4M | Sell |
465,038
-29,148
| -6% | -$1.4M | 2.09% | 8 |
|
2015
Q2 | $25.7M | Buy |
494,186
+464
| +0.1% | +$24.2K | 1.95% | 10 |
|
2015
Q1 | $28.5M | Buy |
493,722
+91,424
| +23% | +$5.27M | 2.04% | 8 |
|
2014
Q4 | $21.5M | Buy |
402,298
+115,716
| +40% | +$6.18M | 1.4% | 24 |
|
2014
Q3 | $16.5M | Buy |
286,582
+139
| +0% | +$7.99K | 0.92% | 47 |
|
2014
Q2 | $19.1M | Sell |
286,443
-135
| -0% | -$9.03K | 1% | 35 |
|
2014
Q1 | $19.1M | Buy |
286,578
+25,803
| +10% | +$1.72M | 1.05% | 32 |
|
2013
Q4 | $17.4M | Buy |
260,775
+11,068
| +4% | +$739K | 1% | 45 |
|
2013
Q3 | $15.7M | Buy |
249,707
+6,260
| +3% | +$393K | 0.93% | 48 |
|
2013
Q2 | $15.2M | Buy |
+243,447
| New | +$15.2M | 1.08% | 41 |
|